搜索结果

Search Results for " influenza b (b/massachusetts/03/2010) hemagglutinin/ha protein (his) "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

* 搜索：		* 机关/企业：
* 邮箱：		* 电话：
备注：
验证码：

Cat. No.	Product Name	Species	Expression System
TMPY-00048	Influenza B (B/Massachusetts/03/2010) Hemagglutinin/HA Protein (His) Harvey rat sarcoma viral oncogene homolog	Influenza B	Baculovirus Insect Cells
	Influenza B (B/Massachusetts/03/2010) Hemagglutinin/HA Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 59.1 kDa and the accession number is L0HRV0.
TMPK-01413	H-2K (b) &B2M&OVA (SIINFEKL) Monomer Protein, Mouse, MHC (His & Avi) H-2K,OVA,MHC,H2-K1	Mouse	HEK293 Cells
	Ovalbumin (OVA) has been historically a popular source of such antigens, since OVA can induce both humoral and cellular immune responses based on well-characterised peptide epitopes. The OVA257-264 octapeptide was one of the frst OVA epitopes to be characterised, it has an amino acid sequence SIINFEKL, which is recognised by cytotoxic T lymphocytes. SIINFEKL forms fbrillar assemblies similar to other peptide hydrogels. Te immunoactive properties of this peptide can therefore be related to its se...
TMPK-01412	HLA-B15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His* & Avi) SARS-CoV-2 epitope,MHC	Human	HEK293 Cells
	HLA-B15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype.
TMPK-01416	HLA-B15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His* & Avi), Biotinylated MHC,SARS-CoV-2 epitope	Human	HEK293 Cells
	HLA-B15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype.
TMPK-01420	Peptide Ready HLA-A03:01&B2M Monomer Protein, Human, MHC (His* & Avi) Peptide Ready,MHC,HLA-A*02:01	Human	HEK293 Cells
	Peptide Ready HLA-A03:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A03:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01417	HLA-A02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His* & Avi), PE-Labeled Alpha-1-fetoprotein,HPAFP,AFPD,AFP,Alp...	Human	HEK293 Cells
	Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed protein*s.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01545	HLA-E01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein, Human, MHC (His* & Avi), Biotinylated sHLA-E,MHC,MHC class I antigen E,HLAE,MHC HLA-E alpha	Human	HEK293 Cells
	HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules ...
TMPK-01423	Peptide Ready HLA-E01:03&B2M Monomer Protein, Human, MHC (His* & Avi), Biotinylated MHC,Peptide Ready,HLA-E*01:03	Human	HEK293 Cells
	HLA-E01:03&B2M&Peptide ready Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-E01:03. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01419	Peptide Ready HLA-A03:01&B2M Monomer Protein, Human, MHC (His* & Avi), Biotinylated MHC,HLA-A*02:01,Peptide Ready	Human	HEK293 Cells
	Peptide Ready HLA-A03:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A03:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01424	Peptide Ready HLA-E01:03&B2M Monomer Protein, Human, MHC (His* & Avi) MHC,HLA-E*01:03,Peptide Ready	Human	HEK293 Cells
	HLA-E01:03&B2M&Peptide ready Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-E01:03. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
TMPK-01456	HLA-C03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer Protein, Human, MHC (His* & Avi) KRAS2,NS,MHC,C-K-RAS,KRAS1,K-RAS2A,K-RAS2B...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01512	HLA-A03:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His* & Avi) K-Ras 2,NS,NS3,K-RAS2B,CFC2,MHC,KRAS1,GTPa...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
TMPK-01483	HLA-A02:03&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His* & Avi), Biotinylated AFPD,AFP,Alpha-fetoprotein,HPAFP,MHC,FETA,...	Human	HEK293 Cells
	Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed protein*s.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01435	HLA-A03:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His* & Avi), PE-Labeled KRAS2,NS3,RASK2,KI-RAS,RALD,K-RAS2B,K-RAS4...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01450	HLA-C03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His* & Avi), Biotinylated KRAS1,MHC,K-RAS4B,KRAS,CFC2,K-RAS2...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01511	HLA-A03:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His* & Avi), Biotinylated GTPase Kras,K-RAS4A,KI-RAS,K-RAS4B,C-K-RAS...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
TMPK-01541	HLA-E01:03&B2M&Peptide (VMAPRTLVL) Tetramer Protein, Human, MHC (His* & Avi), Biotinylated QA1,MHC HLA-E alpha-2.1,MHC,HLAE,MHC class I antige...	Human	HEK293 Cells
	HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules ...
TMPK-01544	HLA-E01:03&B2M&Peptide (VMAPRTLVL) Tetramer Protein, Human, MHC (His* & Avi) MHC class I antigen E,HLAE,sHLA-E,QA1,MHC HLA-E alpha	Human	HEK293 Cells
	HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules ...
TMPK-01526	HLA-A03:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His* & Avi) KRAS,NS3,GTPase Kras,RASK2,K-RAS2B,C-K-RAS...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01453	HLA-A03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His* & Avi), Biotinylated RASK2,CFC2,K-Ras 2,NS3,GTPase Kras,KRAS1,K-RAS4B	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01452	HLA-E01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control Protein, Human, MHC (His* & Avi) HLAE,MHC class I antigen E,MHC,QA1,sHLA-E	Human	HEK293 Cells
	HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules ...
TMPK-01514	HLA-E01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein, Human, MHC (His* & Avi) sHLA-E,MHC class I antigen E,MHC HLA-E alpha-1,MHC,...	Human	HEK293 Cells
	HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules ...
TMPK-01482	HLA-A02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein, Human, MHC (His* & Avi) MHC,AFPD,Alpha-fetoprotein,FETA,Alpha<...	Human	HEK293 Cells
	Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed protein*s.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.
TMPK-01451	HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi) NS3,K-RAS4A,K-Ras 2,NS,KRAS1,RASK2,MHC,KI-RAS,KRAS,CFC2,K-RA...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01527	HLA-A03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His* & Avi) NS,RALD,C-K-RAS,RASK2,K-RAS2B,KRAS2,KRAS,K...	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01510	HLA-A03:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His* & Avi) NS,NS3,KRAS2,RASK2,MHC,RALD,K-Ras 2,K-RAS4B	Human	HEK293 Cells
	Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
TMPK-01484	HLA-A02:03&B2M&AFP (FMNKFIYEI) Monomer Protein, Human, MHC (His* & Avi) HPAFP,FETA,AFP,AFPD,Alpha-1-fetoprotein,MH...	Human	HEK293 Cells
	Alpha-fetoprotein (AFP), a specific liver cancer marker, T cells expressing AFP-CAR selectively degranulated, released cytokines, and lysed liver cancer cells that were HLA-A02:01 /AFP while sparing cells from multiple tissue types that were negative for either expressed protein*s.CAR T-cell immunotherapy targeting intracellular/secreted solid tumor antigens can elicit a potent antitumor response.

搜索结果

提交您的定制咨询

重组蛋白